Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 06:08:04 29/09/26 pm AEST			5-day change	1st Jan Change
9.475 ^HKD	+0.91%		-1.35%	+12.40%

11:38pm	Pharma sector doubles down on AI to slash costs, timelines	RE
09:33pm	CSPC Pharma Gets US FDA Approval to Start Herpes Zoster Vaccine Trial	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	108,167	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	12.23%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	96,950	93,882	90,741
Change	-	-3.79%	-16.18%	-35.07%	84.76%	11.81%	-3.16%	-3.35%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	10.7x	15.7x	14.8x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.41x	2.26x	2.09x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0x	-0.5x	2.23x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.81x	3.03x	2.86x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.52x	2.63x	2.4x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	7.07x	9.8x	8.5x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	7.96x	11.7x	10.7x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	12.7x	14.1x	13.1x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	7.88%	7.08%	7.61%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.4597	0.3682	0.3914
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.85%	3.89%	4.13%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.8882	0.6023	0.6422
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	51.7%	61.1%	60.9%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	38,470	35,682	37,813
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	13,722	9,579	10,675
EBIT ¹	8,366	7,952	7,400	6,113	5,564	12,178	8,040	8,468
Net income ¹	6,901	6,949	6,382	4,632	4,409	10,141	7,017	7,508
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-11,217	-14,285	-17,426
Reference price ²	8.470	8.200	7.260	4.780	8.430	9.475	9.475	9.475
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,416,025	-	-
Announcement Date	22/3/22	22/3/23	20/3/24	28/3/25	25/3/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	10.57x	2.49x	6.99x	4.9%	13.66B
ELI LILLY AND COMPANY	33.68x	12.2x	24.79x	0.59%	1,056B
JOHNSON & JOHNSON	30.25x	6.73x	18.83x	1.97%	655B
ABBVIE INC.	33.7x	7.87x	16.27x	2.61%	471B
ROCHE HOLDING AG	19.34x	4.71x	11.68x	2.82%	342B
NOVARTIS AG	20.6x	5.35x	13.29x	2.98%	277B
ASTRAZENECA PLC	21.11x	4.38x	12.46x	2.02%	257B
AMGEN INC.	26.41x	6.87x	12.24x	2.41%	226B
GILEAD SCIENCES, INC.	-46.04x	6.69x	26.14x	2.16%	189B
NOVO NORDISK A/S	11.29x	4.12x	8.55x	4.45%	170B
Average	16.09x	6.14x	15.13x	2.69%	365.66B
Weighted average by Cap.	24.16x	7.87x	18.13x	1.98%